Impact of Lung Flute Therapy on Asthma

Completed

Conditions studied: Persistent Asthma

In brief

We hypothesized that the ability of the Lung Flute to enhance mucus clearance from the lower airways could be used to improve asthma control, if the device is used on a chronic basis. The primary end point of the study is the comparison of Asthma Control Test (ACT) - a validated questionnaire for asthma control and exhaled NO before, during and after using the lung flute. Several secondary end points were assessed for efficacy and safety, including health status, spirometric lung function, "stepping down" controller therapy and daily albuterol use.

Key facts

Study ID

NCT02003521

Run by

Medical Acoustics LLC

People needed

48

Starts

2013-11-01

Expected to finish

2014-10-01

Last updated by the study team

2014-10-28

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• at least 12 years of age
• diagnosis of asthma and no current or previous history of smoking.

You may not qualify if…

• exacerbation of asthma or hospitalization for asthma within 8 weeks prior to enrollment
• predominant COPD and bronchiectasis by clinical and/or radiological assessment
• history of cough syncope
• pregnant or nursing women
• not fluent in English
• inability to comply with study procedures.

Where it is running

• Buffalo General Medical Center Allergy Clinic — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.